Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Mercia Asset Management – executive interview

Mercia Asset Management – executive interview

Mercia Asset Management — 7 videos in collection

More on this equity

Mercia Asset Management is a regionally focused specialist asset manager with a stated intent to become the leading provider of supportive balance sheet, venture, private equity and debt capital to the UK regions, in transaction sizes typically below £10m.

Life sciences is one of Mercia’s three focus sectors, with seven of its top 20 holdings at 31 March 2020 in the sector, valued at £29m in aggregate or 33% of total portfolio value, with another c 40 earlier-stage life sciences investments held across its third-party managed funds.

In this interview, following the recent life sciences portfolio update, Dr Mark Payton (CEO), Peter Dines (COO and previous head of life sciences) and Dr Mark Wyatt (investment director) discuss Mercia’s approach to investment in the life sciences sector, the impact of COVID-19 and what this might mean for Mercia’s future investment strategy in life sciences.

< Previous
Next >

You may also be interested in these:

TMT

nDreams (Mercia Asset Management) - executive interview

TMT

Soccer Manager (Mercia Asset Management) - executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free